{"id":349392,"date":"2025-08-25T17:20:22","date_gmt":"2025-08-25T17:20:22","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-crinetics-pharmaceuticals\/"},"modified":"2025-08-25T17:20:22","modified_gmt":"2025-08-25T17:20:22","slug":"how-to-buy-crinetics-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349392","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals (CRNX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals (CRNX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Crinetics Pharmaceuticals \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi trong \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh n\u1ed9i ti\u1ebft. V\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 \u0111ang \u0111\u01b0\u1ee3c ph\u00e1t tri\u1ec3n v\u00e0 s\u1ef1 l\u1ea1c quan \u0111\u00e1ng k\u1ec3 t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch, c\u1ed5 phi\u1ebfu n\u00e0y mang l\u1ea1i c\u1ea3 r\u1ee7i ro l\u1edbn v\u00e0 ti\u1ec1m n\u0103ng ph\u1ea7n th\u01b0\u1edfng \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao CRNX x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a h\u00e0nh tr\u00ecnh \u0111\u1ed5i m\u1edbi n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Crinetics Pharmaceuticals \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi trong \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh n\u1ed9i ti\u1ebft. V\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 \u0111ang \u0111\u01b0\u1ee3c ph\u00e1t tri\u1ec3n v\u00e0 s\u1ef1 l\u1ea1c quan \u0111\u00e1ng k\u1ec3 t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch, c\u1ed5 phi\u1ebfu n\u00e0y mang l\u1ea1i c\u1ea3 r\u1ee7i ro l\u1edbn v\u00e0 ti\u1ec1m n\u0103ng ph\u1ea7n th\u01b0\u1edfng \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao CRNX x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a h\u00e0nh tr\u00ecnh \u0111\u1ed5i m\u1edbi n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed C\u1ed5 Phi\u1ebfu CRNX Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Crinetics Pharmaceuticals (CRNX) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>30,99 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y l\u00e0 m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t ph\u1ea1m vi 52 tu\u1ea7n c\u1ee7a c\u1ed5 phi\u1ebfu t\u1eeb 25,56 USD \u0111\u1ebfn 60,69 USD.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y v\u00f4 c\u00f9ng quan tr\u1ecdng. \u0110\u00f3 l\u00e0 khi Crinetics c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <p><strong>Ng\u00e0y 25 th\u00e1ng 9 n\u0103m 2025<\/strong> c\u00f2n quan tr\u1ecdng h\u01a1n - \u0111\u00f3 l\u00e0 ng\u00e0y m\u1ee5c ti\u00eau h\u00e0nh \u0111\u1ed9ng PDUFA c\u1ee7a FDA cho paltusotine, \u1ee9ng vi\u00ean thu\u1ed1c h\u00e0ng \u0111\u1ea7u c\u1ee7a h\u1ecd cho b\u1ec7nh acromegaly. S\u1ef1 ki\u1ec7n nh\u1ecb ph\u00e2n n\u00e0y c\u00f3 th\u1ec3 thay \u0111\u1ed5i \u0111\u00e1ng k\u1ec3 \u0111\u1ecbnh gi\u00e1 c\u00f4ng ty ch\u1ec9 sau m\u1ed9t \u0111\u00eam.<\/p> <h3>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh C\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu CRNX<\/h3> <p>Xem x\u00e9t c\u00e1c ch\u1ea5t x\u00fac t\u00e1c quy \u0111\u1ecbnh g\u1ea7n \u0111\u00e2y cung c\u1ea5p c\u00e1i nh\u00ecn gi\u00e1 tr\u1ecb:<\/p> <ul> <li><strong>Ng\u00e0y 21 th\u00e1ng 8 n\u0103m 2025<\/strong>: FDA c\u1ea5p Quy\u1ec1n \u01afu Ti\u00ean Thu\u1ed1c M\u1ed3 C\u00f4i cho atumelnant - c\u1ed5 phi\u1ebfu ph\u1ea3n \u1ee9ng t\u00edch c\u1ef1c v\u1eeba ph\u1ea3i<\/li> <li><strong>Ng\u00e0y 9 th\u00e1ng 12 n\u0103m 2024<\/strong>: FDA ch\u1ea5p nh\u1eadn NDA cho paltusotine - c\u1ed5 phi\u1ebfu t\u0103ng 18% trong tu\u1ea7n ti\u1ebfp theo<\/li> <li><strong>C\u00e1c d\u1eef li\u1ec7u l\u00e2m s\u00e0ng tr\u01b0\u1edbc \u0111\u00f3<\/strong>: Th\u01b0\u1eddng g\u00e2y ra bi\u1ebfn \u0111\u1ed9ng 15-25% theo c\u1ea3 hai h\u01b0\u1edbng<\/li> <\/ul> <p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh. Nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh \u0111\u1ecbnh v\u1ecb tr\u01b0\u1edbc c\u00e1c s\u1ef1 ki\u1ec7n n\u00e0y \u0111\u1ed3ng th\u1eddi qu\u1ea3n l\u00fd r\u1ee7i ro m\u1ed9t c\u00e1ch ph\u00f9 h\u1ee3p.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng v\u00e0 Ph\u00e2n T\u00edch Xu H\u01b0\u1edbng<\/h2> <p>CRNX \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh th\u0103ng tr\u1ea7m trong s\u00e1u th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 42,50 USD (h\u1ed3i ph\u1ee5c sau k\u1ef3 ngh\u1ec9)<br\/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 35,20 USD (b\u1ea5t \u0111\u1ecbnh trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng)<br\/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 38,90 USD (l\u1ea1c quan t\u1ea1i h\u1ed9i ngh\u1ecb ENDO)<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 30,99 USD (m\u1ee9c hi\u1ec7n t\u1ea1i)<\/p> <p>\u0110i\u1ec1u n\u00e0y \u0111\u1ea1i di\u1ec7n cho <strong>s\u1ef1 gi\u1ea3m 27%<\/strong> so v\u1edbi \u0111\u1ec9nh th\u00e1ng 2, ch\u1ee7 y\u1ebfu do:<\/p> <ul> <li>S\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li>Ch\u1ed1t l\u1eddi sau c\u00e1c m\u1ee9c t\u0103ng tr\u01b0\u1edbc \u0111\u00f3<\/li> <li>Bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh tr\u01b0\u1edbc quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA<\/li> <\/ul> <p>Tuy nhi\u00ean, c\u1ed5 phi\u1ebfu \u0111\u00e3 t\u00ecm th\u1ea5y s\u1ef1 h\u1ed7 tr\u1ee3 m\u1ea1nh quanh m\u1ee9c 30 USD, cho th\u1ea5y \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 tr\u01b0\u1edbc ch\u1ea5t x\u00fac t\u00e1c l\u1edbn ti\u1ebfp theo.<\/p>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n trong pipeline l\u00e2m s\u00e0ng:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 45-55 USD (ph\u1ee5 thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng quy\u1ebft \u0111\u1ecbnh FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br\/> <strong>2026<\/strong>: 65-80 USD (\u0111\u00e0 ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i)<br\/> <strong>2028<\/strong>: 90-120 USD (m\u1edf r\u1ed9ng pipeline v\u00e0 th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng)<br\/> <strong>2030<\/strong>: 150+ USD (tr\u1edf th\u00e0nh nh\u00e0 l\u00e3nh \u0111\u1ea1o \u0111i\u1ec1u tr\u1ecb n\u1ed9i ti\u1ebft \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp)<\/p> <p>S\u1ef1 bi\u1ebfn \u0111\u1ed9ng ph\u1ee5 thu\u1ed9c g\u1ea7n nh\u01b0 ho\u00e0n to\u00e0n v\u00e0o quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA ng\u00e0y 25 th\u00e1ng 9. Ph\u00ea duy\u1ec7t c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t l\u1ee3i nhu\u1eadn ngay l\u1eadp t\u1ee9c 50-100%, trong khi t\u1eeb ch\u1ed1i c\u00f3 th\u1ec3 g\u00e2y gi\u1ea3m 30-50%.<\/p>  <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i ro t\u1eeb vi\u1ec7c FDA t\u1eeb ch\u1ed1i<\/strong>: K\u1ebft qu\u1ea3 nh\u1ecb ph\u00e2n v\u00e0o ng\u00e0y 25 th\u00e1ng 9 c\u00f3 th\u1ec3 r\u1ea5t nghi\u00eam tr\u1ecdng<\/li> <li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n \u00e2m<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do \u00e2m 155 tri\u1ec7u USD c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li> <li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 3 v\u1eabn \u0111ang ch\u1edd cho nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c \u0111\u1ed1i th\u1ee7 l\u1edbn nh\u01b0 Novartis \u0111ang chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3> <ul> <li><strong>Quy\u1ec1n \u01b0u ti\u00ean thu\u1ed1c m\u1ed3 c\u00f4i<\/strong>: Quy\u1ec1n \u01b0u ti\u00ean th\u00e1ng 8 n\u0103m 2025 cho atumelnant mang l\u1ea1i l\u1ee3i th\u1ebf<\/li> <li><strong>\u0110\u1ed3ng thu\u1eadn c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 6 \u0111\u00e1nh gi\u00e1 \"Mua M\u1ea1nh\" v\u1edbi m\u1ee5c ti\u00eau trung b\u00ecnh 74 USD (<a href=\"https:\/\/stockanalysis.com\/stocks\/crnx\/forecast\/\">StockAnalysis<\/a>)<\/li> <li><strong>B\u1ea3ng c\u00e2n \u0111\u1ed1i s\u1ea1ch<\/strong>: T\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu 0% cung c\u1ea5p s\u1ef1 linh ho\u1ea1t t\u00e0i ch\u00ednh<\/li> <li><strong>Ti\u1ec1m n\u0103ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Th\u1ecb tr\u01b0\u1eddng acromegaly tr\u1ecb gi\u00e1 1,3 t\u1ef7 USD \u0111ang ch\u1edd \u0111\u1ee3i \u0111\u1ed5i m\u1edbi<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>Ch\u1edd \u0111\u1ee3i s\u1ef1 gi\u1ea3m gi\u00e1 sau FDA<\/strong>: N\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, mua khi c\u00f3 \u0111i\u1ec1u ch\u1ec9nh gi\u1ea3m 10-15% \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n<\/li> <li><strong>Qu\u1ea3n l\u00fd k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf h\u1ee3p l\u00fd<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi c\u00e1c k\u1ecbch b\u1ea3n t\u1eeb ch\u1ed1i FDA th\u1ea3m kh\u1ed1c<\/li> <li><strong>Theo d\u00f5i \u0111\u1ed9t bi\u1ebfn kh\u1ed1i l\u01b0\u1ee3ng<\/strong>: Ho\u1ea1t \u0111\u1ed9ng giao d\u1ecbch t\u0103ng th\u01b0\u1eddng b\u00e1o hi\u1ec7u c\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn s\u1eafp t\u1edbi<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch CRNX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba - ti\u1ec1m n\u0103ng c\u1ef1c k\u1ef3 h\u1ea5p d\u1eabn, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng th\u00ed nghi\u1ec7m b\u1ea5t ng\u1edd v\u00e0 nh\u1eefng v\u1ee5 n\u1ed5 th\u1ec9nh tho\u1ea3ng!\"<\/p>  <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"CRNX\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 qu\u00e1 cao trong th\u1eddi k\u1ef3 bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf v\u01b0\u1ee3t tr\u1ed9i:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> - Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li> <li><strong>X\u00e1c minh nhanh ch\u00f3ng<\/strong> - KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li> <li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> - Nhi\u1ec1u c\u00e1ch \u0111\u1ec3 truy c\u1eadp l\u1ee3i nhu\u1eadn nhanh ch\u00f3ng<\/li> <li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong> - H\u1ecdc h\u1ecfi trong khi giao d\u1ecbch v\u1edbi ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng to\u00e0n di\u1ec7n<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c \u0111i\u1ec1u h\u01b0\u1edbng bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 d\u00e0ng h\u01a1n nhi\u1ec1u cho ng\u01b0\u1eddi m\u1edbi.<\/p>  <h2>\ud83c\udf0d Crinetics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi N\u1ed9i Ti\u1ebft<\/h2> <p>Crinetics Pharmaceuticals \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u1ed9i ti\u1ebft, t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm v\u1edbi nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn. Pipeline c\u1ee7a c\u00f4ng ty bao g\u1ed3m c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng c\u00e1ch m\u1ea1ng c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u0103m s\u00f3c b\u1ec7nh nh\u00e2n acromegaly, t\u0103ng s\u1ea3n th\u01b0\u1ee3ng th\u1eadn b\u1ea9m sinh v\u00e0 c\u00e1c t\u00ecnh tr\u1ea1ng li\u00ean quan.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Crinetics \u0111\u00e3 ph\u00e1t hi\u1ec7n ra r\u1eb1ng c\u1ea5u tr\u00fac ph\u00e2n t\u1eed c\u1ee7a h\u1ee3p ch\u1ea5t h\u00e0ng \u0111\u1ea7u \u0111\u01b0\u1ee3c l\u1ea5y c\u1ea3m h\u1ee9ng t\u1eeb c\u00e1c m\u1eabu trong h\u1ec7 sinh th\u00e1i r\u1ea1n san h\u00f4 - h\u00f3a h\u1ecdc c\u1ee7a thi\u00ean nhi\u00ean truy\u1ec1n c\u1ea3m h\u1ee9ng cho y h\u1ecdc hi\u1ec7n \u0111\u1ea1i!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed C\u1ed5 Phi\u1ebfu CRNX Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Crinetics Pharmaceuticals (CRNX) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>30,99 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y l\u00e0 m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t ph\u1ea1m vi 52 tu\u1ea7n c\u1ee7a c\u1ed5 phi\u1ebfu t\u1eeb 25,56 USD \u0111\u1ebfn 60,69 USD.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y v\u00f4 c\u00f9ng quan tr\u1ecdng. \u0110\u00f3 l\u00e0 khi Crinetics c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<p><strong>Ng\u00e0y 25 th\u00e1ng 9 n\u0103m 2025<\/strong> c\u00f2n quan tr\u1ecdng h\u01a1n &#8211; \u0111\u00f3 l\u00e0 ng\u00e0y m\u1ee5c ti\u00eau h\u00e0nh \u0111\u1ed9ng PDUFA c\u1ee7a FDA cho paltusotine, \u1ee9ng vi\u00ean thu\u1ed1c h\u00e0ng \u0111\u1ea7u c\u1ee7a h\u1ecd cho b\u1ec7nh acromegaly. S\u1ef1 ki\u1ec7n nh\u1ecb ph\u00e2n n\u00e0y c\u00f3 th\u1ec3 thay \u0111\u1ed5i \u0111\u00e1ng k\u1ec3 \u0111\u1ecbnh gi\u00e1 c\u00f4ng ty ch\u1ec9 sau m\u1ed9t \u0111\u00eam.<\/p>\n<h3>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh C\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu CRNX<\/h3>\n<p>Xem x\u00e9t c\u00e1c ch\u1ea5t x\u00fac t\u00e1c quy \u0111\u1ecbnh g\u1ea7n \u0111\u00e2y cung c\u1ea5p c\u00e1i nh\u00ecn gi\u00e1 tr\u1ecb:<\/p>\n<ul>\n<li><strong>Ng\u00e0y 21 th\u00e1ng 8 n\u0103m 2025<\/strong>: FDA c\u1ea5p Quy\u1ec1n \u01afu Ti\u00ean Thu\u1ed1c M\u1ed3 C\u00f4i cho atumelnant &#8211; c\u1ed5 phi\u1ebfu ph\u1ea3n \u1ee9ng t\u00edch c\u1ef1c v\u1eeba ph\u1ea3i<\/li>\n<li><strong>Ng\u00e0y 9 th\u00e1ng 12 n\u0103m 2024<\/strong>: FDA ch\u1ea5p nh\u1eadn NDA cho paltusotine &#8211; c\u1ed5 phi\u1ebfu t\u0103ng 18% trong tu\u1ea7n ti\u1ebfp theo<\/li>\n<li><strong>C\u00e1c d\u1eef li\u1ec7u l\u00e2m s\u00e0ng tr\u01b0\u1edbc \u0111\u00f3<\/strong>: Th\u01b0\u1eddng g\u00e2y ra bi\u1ebfn \u0111\u1ed9ng 15-25% theo c\u1ea3 hai h\u01b0\u1edbng<\/li>\n<\/ul>\n<p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: c\u00e1c c\u1ed9t m\u1ed1c quy \u0111\u1ecbnh t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh. Nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh \u0111\u1ecbnh v\u1ecb tr\u01b0\u1edbc c\u00e1c s\u1ef1 ki\u1ec7n n\u00e0y \u0111\u1ed3ng th\u1eddi qu\u1ea3n l\u00fd r\u1ee7i ro m\u1ed9t c\u00e1ch ph\u00f9 h\u1ee3p.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng v\u00e0 Ph\u00e2n T\u00edch Xu H\u01b0\u1edbng<\/h2>\n<p>CRNX \u0111\u00e3 tr\u1ea3i qua m\u1ed9t h\u00e0nh tr\u00ecnh th\u0103ng tr\u1ea7m trong s\u00e1u th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 42,50 USD (h\u1ed3i ph\u1ee5c sau k\u1ef3 ngh\u1ec9)<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 35,20 USD (b\u1ea5t \u0111\u1ecbnh trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng)<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 38,90 USD (l\u1ea1c quan t\u1ea1i h\u1ed9i ngh\u1ecb ENDO)<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 30,99 USD (m\u1ee9c hi\u1ec7n t\u1ea1i)<\/p>\n<p>\u0110i\u1ec1u n\u00e0y \u0111\u1ea1i di\u1ec7n cho <strong>s\u1ef1 gi\u1ea3m 27%<\/strong> so v\u1edbi \u0111\u1ec9nh th\u00e1ng 2, ch\u1ee7 y\u1ebfu do:<\/p>\n<ul>\n<li>S\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li>Ch\u1ed1t l\u1eddi sau c\u00e1c m\u1ee9c t\u0103ng tr\u01b0\u1edbc \u0111\u00f3<\/li>\n<li>Bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh tr\u01b0\u1edbc quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA<\/li>\n<\/ul>\n<p>Tuy nhi\u00ean, c\u1ed5 phi\u1ebfu \u0111\u00e3 t\u00ecm th\u1ea5y s\u1ef1 h\u1ed7 tr\u1ee3 m\u1ea1nh quanh m\u1ee9c 30 USD, cho th\u1ea5y \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 tr\u01b0\u1edbc ch\u1ea5t x\u00fac t\u00e1c l\u1edbn ti\u1ebfp theo.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n trong pipeline l\u00e2m s\u00e0ng:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 45-55 USD (ph\u1ee5 thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng quy\u1ebft \u0111\u1ecbnh FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br \/> <strong>2026<\/strong>: 65-80 USD (\u0111\u00e0 ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i)<br \/> <strong>2028<\/strong>: 90-120 USD (m\u1edf r\u1ed9ng pipeline v\u00e0 th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng)<br \/> <strong>2030<\/strong>: 150+ USD (tr\u1edf th\u00e0nh nh\u00e0 l\u00e3nh \u0111\u1ea1o \u0111i\u1ec1u tr\u1ecb n\u1ed9i ti\u1ebft \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp)<\/p>\n<p>S\u1ef1 bi\u1ebfn \u0111\u1ed9ng ph\u1ee5 thu\u1ed9c g\u1ea7n nh\u01b0 ho\u00e0n to\u00e0n v\u00e0o quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA ng\u00e0y 25 th\u00e1ng 9. Ph\u00ea duy\u1ec7t c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t l\u1ee3i nhu\u1eadn ngay l\u1eadp t\u1ee9c 50-100%, trong khi t\u1eeb ch\u1ed1i c\u00f3 th\u1ec3 g\u00e2y gi\u1ea3m 30-50%.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro t\u1eeb vi\u1ec7c FDA t\u1eeb ch\u1ed1i<\/strong>: K\u1ebft qu\u1ea3 nh\u1ecb ph\u00e2n v\u00e0o ng\u00e0y 25 th\u00e1ng 9 c\u00f3 th\u1ec3 r\u1ea5t nghi\u00eam tr\u1ecdng<\/li>\n<li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n \u00e2m<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do \u00e2m 155 tri\u1ec7u USD c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li>\n<li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 3 v\u1eabn \u0111ang ch\u1edd cho nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c \u0111\u1ed1i th\u1ee7 l\u1edbn nh\u01b0 Novartis \u0111ang chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Quy\u1ec1n \u01b0u ti\u00ean thu\u1ed1c m\u1ed3 c\u00f4i<\/strong>: Quy\u1ec1n \u01b0u ti\u00ean th\u00e1ng 8 n\u0103m 2025 cho atumelnant mang l\u1ea1i l\u1ee3i th\u1ebf<\/li>\n<li><strong>\u0110\u1ed3ng thu\u1eadn c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 6 \u0111\u00e1nh gi\u00e1 &#8220;Mua M\u1ea1nh&#8221; v\u1edbi m\u1ee5c ti\u00eau trung b\u00ecnh 74 USD (<a href=\"https:\/\/stockanalysis.com\/stocks\/crnx\/forecast\/\">StockAnalysis<\/a>)<\/li>\n<li><strong>B\u1ea3ng c\u00e2n \u0111\u1ed1i s\u1ea1ch<\/strong>: T\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu 0% cung c\u1ea5p s\u1ef1 linh ho\u1ea1t t\u00e0i ch\u00ednh<\/li>\n<li><strong>Ti\u1ec1m n\u0103ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Th\u1ecb tr\u01b0\u1eddng acromegaly tr\u1ecb gi\u00e1 1,3 t\u1ef7 USD \u0111ang ch\u1edd \u0111\u1ee3i \u0111\u1ed5i m\u1edbi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>Ch\u1edd \u0111\u1ee3i s\u1ef1 gi\u1ea3m gi\u00e1 sau FDA<\/strong>: N\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, mua khi c\u00f3 \u0111i\u1ec1u ch\u1ec9nh gi\u1ea3m 10-15% \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n<\/li>\n<li><strong>Qu\u1ea3n l\u00fd k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf h\u1ee3p l\u00fd<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi c\u00e1c k\u1ecbch b\u1ea3n t\u1eeb ch\u1ed1i FDA th\u1ea3m kh\u1ed1c<\/li>\n<li><strong>Theo d\u00f5i \u0111\u1ed9t bi\u1ebfn kh\u1ed1i l\u01b0\u1ee3ng<\/strong>: Ho\u1ea1t \u0111\u1ed9ng giao d\u1ecbch t\u0103ng th\u01b0\u1eddng b\u00e1o hi\u1ec7u c\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn s\u1eafp t\u1edbi<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch CRNX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba &#8211; ti\u1ec1m n\u0103ng c\u1ef1c k\u1ef3 h\u1ea5p d\u1eabn, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng th\u00ed nghi\u1ec7m b\u1ea5t ng\u1edd v\u00e0 nh\u1eefng v\u1ee5 n\u1ed5 th\u1ec9nh tho\u1ea3ng!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;CRNX&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 qu\u00e1 cao trong th\u1eddi k\u1ef3 bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf v\u01b0\u1ee3t tr\u1ed9i:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> &#8211; Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li>\n<li><strong>X\u00e1c minh nhanh ch\u00f3ng<\/strong> &#8211; KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li>\n<li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> &#8211; Nhi\u1ec1u c\u00e1ch \u0111\u1ec3 truy c\u1eadp l\u1ee3i nhu\u1eadn nhanh ch\u00f3ng<\/li>\n<li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong> &#8211; H\u1ecdc h\u1ecfi trong khi giao d\u1ecbch v\u1edbi ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng to\u00e0n di\u1ec7n<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c \u0111i\u1ec1u h\u01b0\u1edbng bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 d\u00e0ng h\u01a1n nhi\u1ec1u cho ng\u01b0\u1eddi m\u1edbi.<\/p>\n<h2>\ud83c\udf0d Crinetics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi N\u1ed9i Ti\u1ebft<\/h2>\n<p>Crinetics Pharmaceuticals \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u1ed9i ti\u1ebft, t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm v\u1edbi nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn. Pipeline c\u1ee7a c\u00f4ng ty bao g\u1ed3m c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1eddng u\u1ed1ng c\u00e1ch m\u1ea1ng c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u0103m s\u00f3c b\u1ec7nh nh\u00e2n acromegaly, t\u0103ng s\u1ea3n th\u01b0\u1ee3ng th\u1eadn b\u1ea9m sinh v\u00e0 c\u00e1c t\u00ecnh tr\u1ea1ng li\u00ean quan.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Crinetics \u0111\u00e3 ph\u00e1t hi\u1ec7n ra r\u1eb1ng c\u1ea5u tr\u00fac ph\u00e2n t\u1eed c\u1ee7a h\u1ee3p ch\u1ea5t h\u00e0ng \u0111\u1ea7u \u0111\u01b0\u1ee3c l\u1ea5y c\u1ea3m h\u1ee9ng t\u1eeb c\u00e1c m\u1eabu trong h\u1ec7 sinh th\u00e1i r\u1ea1n san h\u00f4 &#8211; h\u00f3a h\u1ecdc c\u1ee7a thi\u00ean nhi\u00ean truy\u1ec1n c\u1ea3m h\u1ee9ng cho y h\u1ecdc hi\u1ec7n \u0111\u1ea1i!<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu CRNX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRNX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ. Ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 \"CRNX\", ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"CRNX c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t thu\u1ed1c, d\u00f2ng ti\u1ec1n \u00e2m l\u1edbn, th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty l\u1edbn."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 CRNX trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"N\u1ebfu FDA ph\u00ea duy\u1ec7t, gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 45-55 USD v\u00e0o cu\u1ed1i n\u0103m 2025 v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng trong c\u00e1c n\u0103m sau, c\u00f3 th\u1ec3 \u0111\u1ea1t tr\u00ean 150 USD v\u00e0o n\u0103m 2030."},{"question":"T\u1ea1i sao n\u00ean ch\u1edd \u0111\u1ee3i sau quy\u1ebft \u0111\u1ecbnh FDA \u0111\u1ec3 mua?","answer":"Vi\u1ec7c ch\u1edd \u0111\u1ee3i s\u1ef1 \u0111i\u1ec1u ch\u1ec9nh gi\u00e1 sau quy\u1ebft \u0111\u1ecbnh FDA gi\u00fap b\u1ea1n mua \u0111\u01b0\u1ee3c c\u1ed5 phi\u1ebfu v\u1edbi gi\u00e1 t\u1ed1t h\u01a1n, gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi gi\u00e1 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu CRNX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRNX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ. Ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 \"CRNX\", ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"CRNX c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t thu\u1ed1c, d\u00f2ng ti\u1ec1n \u00e2m l\u1edbn, th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty l\u1edbn."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 CRNX trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"N\u1ebfu FDA ph\u00ea duy\u1ec7t, gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 45-55 USD v\u00e0o cu\u1ed1i n\u0103m 2025 v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng trong c\u00e1c n\u0103m sau, c\u00f3 th\u1ec3 \u0111\u1ea1t tr\u00ean 150 USD v\u00e0o n\u0103m 2030."},{"question":"T\u1ea1i sao n\u00ean ch\u1edd \u0111\u1ee3i sau quy\u1ebft \u0111\u1ecbnh FDA \u0111\u1ec3 mua?","answer":"Vi\u1ec7c ch\u1edd \u0111\u1ee3i s\u1ef1 \u0111i\u1ec1u ch\u1ec9nh gi\u00e1 sau quy\u1ebft \u0111\u1ecbnh FDA gi\u00fap b\u1ea1n mua \u0111\u01b0\u1ee3c c\u1ed5 phi\u1ebfu v\u1edbi gi\u00e1 t\u1ed1t h\u01a1n, gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi gi\u00e1 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T17:20:22+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)\",\"datePublished\":\"2025-08-25T17:20:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-25T17:20:22+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T17:20:22+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)","datePublished":"2025-08-25T17:20:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-25T17:20:22+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Crinetics Pharmaceuticals, Inc. (CRNX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":349389,"slug":"how-to-buy-crinetics-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Crinetics Pharmaceuticals, Inc. (CRNX) - Investimento em a\u00e7\u00f5es da Crinetics Pharmaceuticals, Inc. (CRNX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-crinetics-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/349392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=349392"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/349392\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=349392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=349392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=349392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}